Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites

被引:0
|
作者
Yamamoto, H
Kishi, T
Lee, CE
Choi, BJ
Fang, H
Hollenberg, AN
Drucker, DJ
Elmquist, JK
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA
[5] Toronto Gen Hosp, Dept Med, Toronto, ON M5G 2C4, Canada
[6] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada
来源
JOURNAL OF NEUROSCIENCE | 2003年 / 23卷 / 07期
关键词
GLP-1; area postrema; tyrosine hydroxylase; blood-brain barrier; insulin; c-Fos; catecholamine neurons; autonomic regulatory system;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like peptide-1 (GLP-1) released from the gut is an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that has diverse central actions, including inhibition of food and water intake, gastric emptying, and stimulation of neuroendocrine responses characteristic of visceral illness. Both intravenous and intracerebroventricular administration of GLP-1 receptor (GLP-1R) agonists increase blood pressure and heart rate and induce Fos-like immunoreactivity (Fos-IR) in autonomic regulatory sites in the rat brain. The area postrema (AP) is a circumventricular organ and has been implicated in processing visceral sensory information. GLP-1Rs are densely expressed in the AP, and peripheral GLP-1R agonists induce Fos-IR in AP neurons to a greater degree than intracerebroventricular administration. Because the AP lacks a blood-brain barrier, we hypothesized that the AP is a key site for peripheral GLP-1 to activate central autonomic regulatory sites. In this study, we found that many tyrosine hydroxylase (TH)-containing neurons in the AP expressed GLP-1Rs and Fos-IR after intravenous GLP-1R agonists. Furthermore, intravenous but not intracerebroventricular GLP-1R agonists induced TH transcription in the AP in vivo. In addition, GLP-1R agonists directly activated TH transcription in an in vitro cell system. Finally, we found that GLP-1-responsive TH neurons in the AP innervate autonomic control sites, including the parabrachial nucleus, nucleus of solitary tract, and ventrolateral medulla. These findings suggest that catecholamine neurons in the AP link peripheral GLP-1 and central autonomic control sites that mediate the diverse neuroendocrine and autonomic actions of peripheral GLP-1.
引用
收藏
页码:2939 / 2946
页数:8
相关论文
共 50 条
  • [21] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
    Nerup, Nikolaj
    Ambrus, Rikard
    Lindhe, Joanna
    Achiam, Michael P.
    Jeppesen, Palle B.
    Svendsen, Lars B.
    MICROCIRCULATION, 2019, 26 (03)
  • [22] Glucagon-like peptide-1: The missing link in the metabolic clock?
    Brubaker, Patricia L.
    Gil-Lozano, Manuel
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 : 70 - 75
  • [23] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [24] Glucagon-like peptide-1, a matter of taste?
    Jensterle, Mojca
    DeVries, J. Hans
    Battelino, Tadej
    Battelino, Saba
    Yildiz, Bulent
    Janez, Andrej
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (04): : 763 - 775
  • [25] Is ghrelin a glucagon-like peptide-1 secretagogue?
    Ueno, Hiroaki
    Nakazato, Masamitsu
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (04) : 466 - 467
  • [26] Glucagon-Like Peptide-1 Gene Therapy
    Rowzee, Anne M.
    Cawley, Niamh X.
    Chiorini, John A.
    Di Pasquale, Giovanni
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [27] Glucagon-Like Peptide-1 and Diabetes 2012
    Monami, Matteo
    Di Pasquale, Giovanni
    Rowzee, Anna
    Rotella, Carlo Maria
    Mannucci, Edoardo
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [28] Glucagon-like peptide-1 and energy homeostasis
    Burcelin, Remy
    Cani, Patrice D.
    Knauf, Claude
    JOURNAL OF NUTRITION, 2007, 137 (11): : 2534S - 2538S
  • [29] Glucagon-like peptide-1 and islet lipolysis
    Winzell, MS
    Ahrén, B
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 795 - 803
  • [30] Glucagon-like peptide-1 and safety - Reply
    Bloom, SR
    NATURE, 1997, 385 (6613) : 214 - 214